相关实验视频

Updated: Sep 17, 2025

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

炎症蛋白调解肠道微生物群对Graves眼科病的影响:孟德尔的随机化研究

Yipao Li^1,2, Lu Chen^1,2, Shaokai Lin^1,2

¹National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China.

Translational vision science & technology

|June 27, 2025

概括

肠道微生物组通过炎症蛋白质影响格雷夫斯眼病 (GO). 像Parabacteroides这样的特定细菌可能会保护GO,提供潜在的治疗点.

科学领域:

遗传学是一个遗传学.
免疫学免疫学免疫学
微生物学微生物学

背景情况:

格雷夫斯眼病 (GO) 是一种影响眼睛的自身免疫性疾病.
肠道微生物群在GO病原发生中的作用尚未完全理解.
炎症蛋白与GO的发展有关.

研究的目的:

调查肠道微生物群 (GM) 和GO之间的因果关系.
探索在转基因-转基因关联中循环炎症蛋白 (IPs) 的调解作用.

主要方法:

两个步骤,两个样本的孟德尔随机化 (MR) 分析.
利用大规模的转基因,GO和IPs的遗传数据.
采用了各种MR方法,包括逆方差加权和调度MR.

主要成果:

确定了26个转基因分类物种与GO.因果相关.
帕拉巴克特罗伊德斯 (Parabacteroides) 属显示出对GO的保护作用.
CXCL10调解了从Parabacteroides到GO的途径,这表明了一个特定的机制.

结论:

确立了转基因和基因组之间的因果关系,由IPs调解.
突出了GO预防和治疗的潜在治疗目标.
提供了对GO病原体的新见解.

更多相关视频

Effects of Taste Signaling Protein Abolishment on Gut Inflammation in an Inflammatory Bowel Disease Mouse Model

Effects of Taste Signaling Protein Abolishment on Gut Inflammation in an Inflammatory Bowel Disease Mouse Model

Published on: November 9, 2018

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

相关概念视频

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

Inflammatory Bowel Disease II: Crohn's Disease

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...